Streetbeat News

Stock Prices

BNBUSD

BTCUSD

Cryptocurrency token ORDI, linked to the Bitcoin Ordinals framework, has seen a 50% increase in value following its listing on Binance. Binance has warned potential investors about the high volatility of the new token. The Ordinals protocol, which underpins the ORDI token, allows for the incorporation of data onto the Bitcoin blockchain through inscriptions. The listing saw the ORDI token's value rise to $11 from the previous $7 range, with trading volumes reaching nearly $100 million within a 24-hour period.

Portfolio Pulse from Murtuza Merchant

November 07, 2023 | 2:26 pm

INGR

Ingredion Inc reported Q3 FY23 sales growth of 1% YoY to $2.03 billion, missing the analyst consensus estimate of $2.114 billion. The revenue increase was driven by price mix and foreign exchange impacts, partially offset by volume declines. Adjusted EPS of $2.33 beat the consensus estimate of $1.95. The company raised its FY23 adjusted EPS outlook from $8.80 - $9.40 to $9.05 - $9.45 against the consensus of $9.00. INGR shares closed lower by 0.28% at $95.62 on Monday.

Portfolio Pulse from Shivani Kumaresan

November 07, 2023 | 2:25 pm

VTYX

Ventyx Biosciences Inc (NASDAQ:VTYX) has announced disappointing results from the Phase 2 trial of VTX958 in patients with moderate to severe plaque psoriasis. Despite achieving statistical significance on the primary endpoint and all key secondary endpoints, the efficacy observed did not meet the company's internal target. As a result, Ventyx Biosciences will terminate ongoing activities in the Phase 2 plaque psoriasis trial and the ongoing Phase 2 trial of VTX958 in psoriatic arthritis. The company's stock is down 78.70% in premarket trading.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 2:23 pm

AAPL

DASH

DDOG

DIS

NVDA

QQQ

RIVN

TSLA

UBER

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:11 pm

IBRX

The correct ticker symbol for ImmunityBio is 'IBRX', not 'IBRC'.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 2:08 pm

CPRT

PLTR

SOFI

UEC

Jim Cramer, host of CNBC's 'Mad Money Lightning Round', gave his opinions on several stocks. He recommended Uranium Energy Corp. (UEC), Blackstone Inc. (BX), and SoFi Technologies, Inc. (SOFI), and praised Copart, Inc. (CPRT). He was negative about BP p.l.c. (BP) and had a change of heart about Palantir Technologies Inc. (PLTR), which he said reported a 'dynamite' quarter.

Portfolio Pulse from Lisa Levin

November 07, 2023 | 2:05 pm

ASH

Ashland (NYSE:ASH) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $0.87. The company's past performance shows a trend of missing EPS estimates, which has led to drops in share price. Ashland's shares were trading at $77.26 as of November 3, with a 26.5% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 2:02 pm

XENE

Xenon Pharmaceuticals (NASDAQ:XENE) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.77. The company's past performance shows a pattern of share price changes following earnings reports. The stock was trading at $32.86 as of November 3, with a 0.6% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 2:01 pm

AMPH

Amphastar Pharma (NASDAQ:AMPH) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $0.69. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $46.83 and has seen a 65.71% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 2:01 pm

RVNC

Revance Therapeutics (NASDAQ:RVNC) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.90. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $9.08, down 56.4% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 2:01 pm